Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial's eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 381 - 400 of 513 trials
Titlesort icon Investigator Disease(s)
A Phase I/II Study of BMS-986012 in Patients with Persistent or Recurrent Metastatic Small Cell Lung Cancer
[Protocol 14-239]
Krug, Lee
  • Lung Cancer, Small Cell
A Phase I/II Study of ASP2215 in Patients with Recurrent or Persistent Acute Myeloid Leukemia
[Protocol 14-196]
Berman, Ellin
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase I/II Study of AG-221 in Patients with Advanced Solid Tumors (including Glioma) or Angioimmunoblastic T-Cell Lymphoma that Have an IDH2 Mutation
[Protocol 14-254]
Mellinghoff, Ingo
  • Brain Tumors, Primary
    • Gliomas
  • Lymphoma
    • Non-Hodgkin's Lymphoma
  • Solid Tumors
A Phase I/II Study Assessing BPX-501 T Cells Given After Partially Mismatched Related T Cell-Depleted Stem Cell Transplantation in Patients with Hematologic Cancers
[Protocol 13-181]
Perales, Miguel-Angel
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096]
Trippett, Tanya
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114]
Park, Jae
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175]
Koehne, Guenther
  • Hematology
    • Multiple Myeloma
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
A Phase I Study of VS-5584 plus VS-6063 in Patients with Relapsed Malignant Mesothelioma
[Protocol 15-004]
Zauderer, Marjorie
  • Mesothelioma
A Phase I Study of VS-5584 in Patients with Lymphoma or Advanced Solid Tumors
[Protocol 14-065]
Varghese, Anna
  • Lymphoma
  • Solid Tumors
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-198]
Dunkel, Ira
  • Melanoma
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario
  • Breast Cancer
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164]
Boulad, Farid
  • Hematology
    • Hematologic Disorders
  • Pediatric Blood Disorders
A Phase I Study of the Immune Activity and Safety of IMC-CS4 in Patients with Advanced Breast or Prostate Cancers
[Protocol 14-204]
Autio, Karen
  • Breast Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of TAS-119 plus Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-149]
Drilon, Alexander
  • Solid Tumors
A Phase I Study of TAS-102 plus CPT-11 (Irinotecan) in Patients with Advanced Digestive Cancers
[Protocol 13-105]
Saltz, Leonard
  • Colorectal Cancer
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase I Study of STM 434 in Patients with Ovarian Cancer and Other Advanced Solid Tumors
[Protocol 14-132]
Hyman, David
  • Ovarian Cancer
  • Solid Tumors